Global Rare Disease CRO Service Market 2026 by Company, Regions, Type and Application, Forecast to 2032

1 Market Overview

• 1.1 Product Overview and Scope
• 1.2 Market Estimation Caveats and Base Year
• 1.3 Classification of Rare Disease CRO Service by Type
  • 1.3.1 Overview: Global Rare Disease CRO Service Market Size by Type: 2021 Versus 2025 Versus 2032
  • 1.3.2 Global Rare Disease CRO Service Consumption Value Market Share by Type in 2025
  • 1.3.3 Drug Development Strategy
  • 1.3.4 Clinical Trial Management
• 1.4 Global Rare Disease CRO Service Market by Application
  • 1.4.1 Overview: Global Rare Disease CRO Service Market Size by Application: 2021 Versus 2025 Versus 2032
  • 1.4.2 Cardiovascular
  • 1.4.3 Neuroscience
  • 1.4.4 Ophthalmology
  • 1.4.5 Others
• 1.5 Global Rare Disease CRO Service Market Size & Forecast
• 1.6 Global Rare Disease CRO Service Market Size and Forecast by Region
  • 1.6.1 Global Rare Disease CRO Service Market Size by Region: 2021 VS 2025 VS 2032
  • 1.6.2 Global Rare Disease CRO Service Market Size by Region, (2021-2032)
  • 1.6.3 North America Rare Disease CRO Service Market Size and Prospect (2021-2032)
  • 1.6.4 Europe Rare Disease CRO Service Market Size and Prospect (2021-2032)
  • 1.6.5 Asia-Pacific Rare Disease CRO Service Market Size and Prospect (2021-2032)
  • 1.6.6 South America Rare Disease CRO Service Market Size and Prospect (2021-2032)
  • 1.6.7 Middle East & Africa Rare Disease CRO Service Market Size and Prospect (2021-2032)

2 Company Profiles

• 2.1 Precision for Medicine
  • 2.1.1 Precision for Medicine Details
  • 2.1.2 Precision for Medicine Major Business
  • 2.1.3 Precision for Medicine Rare Disease CRO Service Product and Solutions
  • 2.1.4 Precision for Medicine Rare Disease CRO Service Revenue, Gross Margin and Market Share (2021-2026)
  • 2.1.5 Precision for Medicine Recent Developments and Future Plans
• 2.2 Orphan-Reach
  • 2.2.1 Orphan-Reach Details
  • 2.2.2 Orphan-Reach Major Business
  • 2.2.3 Orphan-Reach Rare Disease CRO Service Product and Solutions
  • 2.2.4 Orphan-Reach Rare Disease CRO Service Revenue, Gross Margin and Market Share (2021-2026)
  • 2.2.5 Orphan-Reach Recent Developments and Future Plans
• 2.3 Medpace
  • 2.3.1 Medpace Details
  • 2.3.2 Medpace Major Business
  • 2.3.3 Medpace Rare Disease CRO Service Product and Solutions
  • 2.3.4 Medpace Rare Disease CRO Service Revenue, Gross Margin and Market Share (2021-2026)
  • 2.3.5 Medpace Recent Developments and Future Plans
• 2.4 Parexel
  • 2.4.1 Parexel Details
  • 2.4.2 Parexel Major Business
  • 2.4.3 Parexel Rare Disease CRO Service Product and Solutions
  • 2.4.4 Parexel Rare Disease CRO Service Revenue, Gross Margin and Market Share (2021-2026)
  • 2.4.5 Parexel Recent Developments and Future Plans
• 2.5 PPD
  • 2.5.1 PPD Details
  • 2.5.2 PPD Major Business
  • 2.5.3 PPD Rare Disease CRO Service Product and Solutions
  • 2.5.4 PPD Rare Disease CRO Service Revenue, Gross Margin and Market Share (2021-2026)
  • 2.5.5 PPD Recent Developments and Future Plans
• 2.6 Worldwide Clinical Trials
  • 2.6.1 Worldwide Clinical Trials Details
  • 2.6.2 Worldwide Clinical Trials Major Business
  • 2.6.3 Worldwide Clinical Trials Rare Disease CRO Service Product and Solutions
  • 2.6.4 Worldwide Clinical Trials Rare Disease CRO Service Revenue, Gross Margin and Market Share (2021-2026)
  • 2.6.5 Worldwide Clinical Trials Recent Developments and Future Plans
• 2.7 AllStripes
  • 2.7.1 AllStripes Details
  • 2.7.2 AllStripes Major Business
  • 2.7.3 AllStripes Rare Disease CRO Service Product and Solutions
  • 2.7.4 AllStripes Rare Disease CRO Service Revenue, Gross Margin and Market Share (2021-2026)
  • 2.7.5 AllStripes Recent Developments and Future Plans
• 2.8 LabCorp
  • 2.8.1 LabCorp Details
  • 2.8.2 LabCorp Major Business
  • 2.8.3 LabCorp Rare Disease CRO Service Product and Solutions
  • 2.8.4 LabCorp Rare Disease CRO Service Revenue, Gross Margin and Market Share (2021-2026)
  • 2.8.5 LabCorp Recent Developments and Future Plans
• 2.9 Novotech
  • 2.9.1 Novotech Details
  • 2.9.2 Novotech Major Business
  • 2.9.3 Novotech Rare Disease CRO Service Product and Solutions
  • 2.9.4 Novotech Rare Disease CRO Service Revenue, Gross Margin and Market Share (2021-2026)
  • 2.9.5 Novotech Recent Developments and Future Plans
• 2.10 Syneos Health
  • 2.10.1 Syneos Health Details
  • 2.10.2 Syneos Health Major Business
  • 2.10.3 Syneos Health Rare Disease CRO Service Product and Solutions
  • 2.10.4 Syneos Health Rare Disease CRO Service Revenue, Gross Margin and Market Share (2021-2026)
  • 2.10.5 Syneos Health Recent Developments and Future Plans
• 2.11 Vial
  • 2.11.1 Vial Details
  • 2.11.2 Vial Major Business
  • 2.11.3 Vial Rare Disease CRO Service Product and Solutions
  • 2.11.4 Vial Rare Disease CRO Service Revenue, Gross Margin and Market Share (2021-2026)
  • 2.11.5 Vial Recent Developments and Future Plans
• 2.12 Machaon Diagnostics
  • 2.12.1 Machaon Diagnostics Details
  • 2.12.2 Machaon Diagnostics Major Business
  • 2.12.3 Machaon Diagnostics Rare Disease CRO Service Product and Solutions
  • 2.12.4 Machaon Diagnostics Rare Disease CRO Service Revenue, Gross Margin and Market Share (2021-2026)
  • 2.12.5 Machaon Diagnostics Recent Developments and Future Plans
• 2.13 Caidya
  • 2.13.1 Caidya Details
  • 2.13.2 Caidya Major Business
  • 2.13.3 Caidya Rare Disease CRO Service Product and Solutions
  • 2.13.4 Caidya Rare Disease CRO Service Revenue, Gross Margin and Market Share (2021-2026)
  • 2.13.5 Caidya Recent Developments and Future Plans
• 2.14 Simbec Orion
  • 2.14.1 Simbec Orion Details
  • 2.14.2 Simbec Orion Major Business
  • 2.14.3 Simbec Orion Rare Disease CRO Service Product and Solutions
  • 2.14.4 Simbec Orion Rare Disease CRO Service Revenue, Gross Margin and Market Share (2021-2026)
  • 2.14.5 Simbec Orion Recent Developments and Future Plans
• 2.15 Linical
  • 2.15.1 Linical Details
  • 2.15.2 Linical Major Business
  • 2.15.3 Linical Rare Disease CRO Service Product and Solutions
  • 2.15.4 Linical Rare Disease CRO Service Revenue, Gross Margin and Market Share (2021-2026)
  • 2.15.5 Linical Recent Developments and Future Plans
• 2.16 MMS
  • 2.16.1 MMS Details
  • 2.16.2 MMS Major Business
  • 2.16.3 MMS Rare Disease CRO Service Product and Solutions
  • 2.16.4 MMS Rare Disease CRO Service Revenue, Gross Margin and Market Share (2021-2026)
  • 2.16.5 MMS Recent Developments and Future Plans
• 2.17 Veristat
  • 2.17.1 Veristat Details
  • 2.17.2 Veristat Major Business
  • 2.17.3 Veristat Rare Disease CRO Service Product and Solutions
  • 2.17.4 Veristat Rare Disease CRO Service Revenue, Gross Margin and Market Share (2021-2026)
  • 2.17.5 Veristat Recent Developments and Future Plans
• 2.18 Celero
  • 2.18.1 Celero Details
  • 2.18.2 Celero Major Business
  • 2.18.3 Celero Rare Disease CRO Service Product and Solutions
  • 2.18.4 Celero Rare Disease CRO Service Revenue, Gross Margin and Market Share (2021-2026)
  • 2.18.5 Celero Recent Developments and Future Plans
• 2.19 Rho
  • 2.19.1 Rho Details
  • 2.19.2 Rho Major Business
  • 2.19.3 Rho Rare Disease CRO Service Product and Solutions
  • 2.19.4 Rho Rare Disease CRO Service Revenue, Gross Margin and Market Share (2021-2026)
  • 2.19.5 Rho Recent Developments and Future Plans
• 2.20 PROMETRIKA
  • 2.20.1 PROMETRIKA Details
  • 2.20.2 PROMETRIKA Major Business
  • 2.20.3 PROMETRIKA Rare Disease CRO Service Product and Solutions
  • 2.20.4 PROMETRIKA Rare Disease CRO Service Revenue, Gross Margin and Market Share (2021-2026)
  • 2.20.5 PROMETRIKA Recent Developments and Future Plans

3 Market Competition, by Players

• 3.1 Global Rare Disease CRO Service Revenue and Share by Players (2021-2026)
• 3.2 Market Share Analysis (2025)
  • 3.2.1 Market Share of Rare Disease CRO Service by Company Revenue
  • 3.2.2 Top 3 Rare Disease CRO Service Players Market Share in 2025
  • 3.2.3 Top 6 Rare Disease CRO Service Players Market Share in 2025
• 3.3 Rare Disease CRO Service Market: Overall Company Footprint Analysis
  • 3.3.1 Rare Disease CRO Service Market: Region Footprint
  • 3.3.2 Rare Disease CRO Service Market: Company Product Type Footprint
  • 3.3.3 Rare Disease CRO Service Market: Company Product Application Footprint
• 3.4 New Market Entrants and Barriers to Market Entry
• 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

• 4.1 Global Rare Disease CRO Service Consumption Value and Market Share by Type (2021-2026)
• 4.2 Global Rare Disease CRO Service Market Forecast by Type (2027-2032)

5 Market Size Segment by Application

• 5.1 Global Rare Disease CRO Service Consumption Value Market Share by Application (2021-2026)
• 5.2 Global Rare Disease CRO Service Market Forecast by Application (2027-2032)

6 North America

• 6.1 North America Rare Disease CRO Service Consumption Value by Type (2021-2032)
• 6.2 North America Rare Disease CRO Service Market Size by Application (2021-2032)
• 6.3 North America Rare Disease CRO Service Market Size by Country
  • 6.3.1 North America Rare Disease CRO Service Consumption Value by Country (2021-2032)
  • 6.3.2 United States Rare Disease CRO Service Market Size and Forecast (2021-2032)
  • 6.3.3 Canada Rare Disease CRO Service Market Size and Forecast (2021-2032)
  • 6.3.4 Mexico Rare Disease CRO Service Market Size and Forecast (2021-2032)

7 Europe

• 7.1 Europe Rare Disease CRO Service Consumption Value by Type (2021-2032)
• 7.2 Europe Rare Disease CRO Service Consumption Value by Application (2021-2032)
• 7.3 Europe Rare Disease CRO Service Market Size by Country
  • 7.3.1 Europe Rare Disease CRO Service Consumption Value by Country (2021-2032)
  • 7.3.2 Germany Rare Disease CRO Service Market Size and Forecast (2021-2032)
  • 7.3.3 France Rare Disease CRO Service Market Size and Forecast (2021-2032)
  • 7.3.4 United Kingdom Rare Disease CRO Service Market Size and Forecast (2021-2032)
  • 7.3.5 Russia Rare Disease CRO Service Market Size and Forecast (2021-2032)
  • 7.3.6 Italy Rare Disease CRO Service Market Size and Forecast (2021-2032)

8 Asia-Pacific

• 8.1 Asia-Pacific Rare Disease CRO Service Consumption Value by Type (2021-2032)
• 8.2 Asia-Pacific Rare Disease CRO Service Consumption Value by Application (2021-2032)
• 8.3 Asia-Pacific Rare Disease CRO Service Market Size by Region
  • 8.3.1 Asia-Pacific Rare Disease CRO Service Consumption Value by Region (2021-2032)
  • 8.3.2 China Rare Disease CRO Service Market Size and Forecast (2021-2032)
  • 8.3.3 Japan Rare Disease CRO Service Market Size and Forecast (2021-2032)
  • 8.3.4 South Korea Rare Disease CRO Service Market Size and Forecast (2021-2032)
  • 8.3.5 India Rare Disease CRO Service Market Size and Forecast (2021-2032)
  • 8.3.6 Southeast Asia Rare Disease CRO Service Market Size and Forecast (2021-2032)
  • 8.3.7 Australia Rare Disease CRO Service Market Size and Forecast (2021-2032)

9 South America

• 9.1 South America Rare Disease CRO Service Consumption Value by Type (2021-2032)
• 9.2 South America Rare Disease CRO Service Consumption Value by Application (2021-2032)
• 9.3 South America Rare Disease CRO Service Market Size by Country
  • 9.3.1 South America Rare Disease CRO Service Consumption Value by Country (2021-2032)
  • 9.3.2 Brazil Rare Disease CRO Service Market Size and Forecast (2021-2032)
  • 9.3.3 Argentina Rare Disease CRO Service Market Size and Forecast (2021-2032)

10 Middle East & Africa

• 10.1 Middle East & Africa Rare Disease CRO Service Consumption Value by Type (2021-2032)
• 10.2 Middle East & Africa Rare Disease CRO Service Consumption Value by Application (2021-2032)
• 10.3 Middle East & Africa Rare Disease CRO Service Market Size by Country
  • 10.3.1 Middle East & Africa Rare Disease CRO Service Consumption Value by Country (2021-2032)
  • 10.3.2 Turkey Rare Disease CRO Service Market Size and Forecast (2021-2032)
  • 10.3.3 Saudi Arabia Rare Disease CRO Service Market Size and Forecast (2021-2032)
  • 10.3.4 UAE Rare Disease CRO Service Market Size and Forecast (2021-2032)

11 Market Dynamics

• 11.1 Rare Disease CRO Service Market Drivers
• 11.2 Rare Disease CRO Service Market Restraints
• 11.3 Rare Disease CRO Service Trends Analysis
• 11.4 Porters Five Forces Analysis
  • 11.4.1 Threat of New Entrants
  • 11.4.2 Bargaining Power of Suppliers
  • 11.4.3 Bargaining Power of Buyers
  • 11.4.4 Threat of Substitutes
  • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

• 12.1 Rare Disease CRO Service Industry Chain
• 12.2 Rare Disease CRO Service Upstream Analysis
• 12.3 Rare Disease CRO Service Midstream Analysis
• 12.4 Rare Disease CRO Service Downstream Analysis

13 Research Findings and Conclusion

14 Appendix

• 14.1 Methodology
• 14.2 Research Process and Data Source